BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,899,856 | +7.2% | 156,329 | +27.0% | 0.01% | -16.7% |
Q2 2023 | $5,502,078 | +42555.1% | 123,089 | -61.5% | 0.01% | -70.0% |
Q1 2023 | $12,899 | +128.8% | 319,993 | +189.3% | 0.02% | +122.2% |
Q4 2022 | $5,637 | -99.9% | 110,600 | -25.7% | 0.01% | -30.8% |
Q3 2022 | $8,237,000 | +134.4% | 148,948 | +178.9% | 0.01% | +116.7% |
Q2 2022 | $3,514,000 | -8.8% | 53,400 | +10.0% | 0.01% | +20.0% |
Q1 2022 | $3,854,000 | -59.5% | 48,554 | -58.3% | 0.01% | -54.5% |
Q3 2021 | $9,520,000 | +209.4% | 116,370 | +215.5% | 0.01% | +37.5% |
Q4 2019 | $3,077,000 | +95.6% | 36,883 | +101.5% | 0.01% | +60.0% |
Q3 2019 | $1,573,000 | +357.3% | 18,302 | +233.4% | 0.01% | +400.0% |
Q3 2017 | $344,000 | +5.8% | 5,490 | +1.5% | 0.00% | 0.0% |
Q2 2017 | $325,000 | +39.5% | 5,409 | +21.6% | 0.00% | 0.0% |
Q1 2017 | $233,000 | -96.6% | 4,450 | -97.1% | 0.00% | -97.1% |
Q4 2016 | $6,854,000 | -9.1% | 154,595 | -3.8% | 0.03% | -2.9% |
Q3 2016 | $7,544,000 | – | 160,780 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |